About us

CATO SMS is an international regulatory and clinical contract research organization (CRO) that has been delivering successful outcomes for its clients since 1988. Through highly qualified and experienced personnel located in offices across North America, Europe, Israel and South Africa, supported by strategic alliances with selected regional CROs, CATO SMS offers tried-and-trusted international coverage. CATO SMS has the advantage of integrated regulatory, clinical and scientific expertise. We bring a powerful blend of capabilities focused on supporting small and mid-sized biotech, top-tier pharmaceutical companies and investigator groups with their innovative research. We provide a complete range of services to pharmaceutical, biotechnology and medical device companies with a flexible and tailor-made approach to the specific needs of every project, either as a full-service solution or by providing stand-alone services to our clients.

Products and services

CATO SMS has in-house capabilities to assist sponsors with all aspects of the drug development process.

  • Regulatory assessments and strategy development
  • Interactions with regulators, including authoring and managing submissions
  • Preclinical/toxicology development programs; study management and monitoring
  • Pharmacokinetic study design and management
    Clinical strategy
  • Phase 1 through Phase 4 clinical study design, implementation, trial management and monitoring services
  • Data management
  • Statistical analyses and integrated statistical/clinical study reports
  • Medical affairs
  • Medical writing
  • Program and project management
  • Safety and pharmacovigilance
  • Chemistry, manufacturing, and control programs
    Quality Clinical Trial Oversight
  • Quality assurance, including audit and compliance activities for GCP, GLP and GMP
  • Due diligence activities for emerging technologies

CATO SMS’s integrated regulatory and clinical competencies offers a unique resource that focuses on your corporate objectives and that can deliver results.

Address
CATO Europe GmbH
Hertzstr. 7
50859 Cologne
Germany

Phone: +49 2234 3794431
Internet: www.cato.com
E-mail: Send message

Contact person

David Surjo
Director Business Development Europe
Phone: +49 2234 3794431
E-mail: Send message

Representative
Cato Research LLC
4364 South Alston Avenue
NC 27713 Durham
USA

Phone: +1 919 3612286
Fax: +1 919-361-2290
Internet: www.cato.com
E-mail: Send message

News & Innovations

CATO RESEARCH ANNOUNCES MERGER WITH SMS-ONCOLOGY Combination Broadens Company’s Global Solutions Supporting Drug Development
DURHAM, NC – October 28, 2019 - Cato Research, LLC (CATO) announced today that it has merged with Specialized Medical Services-oncology BV (SMS-oncology) to bolster its portfolio of global solutions dedicated to supporting life science organizations with advancing drug development. The combined company will transition to the new name, CATO SMS, in the coming year.

By joining forces, CATO and SMS-oncology expand their presence across Europe and North America, deepen their oncology and regulatory expertise, and broaden their suite of services. Headquartered in Schiphol, the Netherlands, SMS-oncology is one of the few full-service contract research organizations (CROs) in the world dedicated to oncology. The boutique CRO’s deep expertise in designing and executing complex oncology and immuno-oncology trials complements CATO’s regulatory knowledge and drug development services.
Further reading

Click here if you notice an image that violates copyright or privacy rights.

Get in contact
OK

We use cookies and the web analysis tool Matomo in order to optimally design and continuously improve our website for you. By continuing to use our website, you agree to this. Further information and an objection possibility can be found here: Data protection